129 related articles for article (PubMed ID: 7930265)
1. gamma-Glutamylcysteine ethyl ester for myocardial protection in dogs during ischemia and reperfusion.
Hoshida S; Kuzuya T; Yamashita N; Nishida M; Kitahara S; Hori M; Kamada T; Tada M
J Am Coll Cardiol; 1994 Nov; 24(5):1391-7. PubMed ID: 7930265
[TBL] [Abstract][Full Text] [Related]
2. The cardioprotective effect of gamma-glutamylcysteine ethyl ester during coronary reperfusion in canine hearts.
Nishinaka Y; Kitahara S; Sugiyama S; Yokota M; Saito H; Ozawa T
Br J Pharmacol; 1991 Dec; 104(4):805-10. PubMed ID: 1810596
[TBL] [Abstract][Full Text] [Related]
3. Ebselen protects against ischemia-reperfusion injury in a canine model of myocardial infarction.
Hoshida S; Kuzuya T; Nishida M; Yamashita N; Hori M; Kamada T; Tada M
Am J Physiol; 1994 Dec; 267(6 Pt 2):H2342-7. PubMed ID: 7810734
[TBL] [Abstract][Full Text] [Related]
4. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.
Mizumura T; Nithipatikom K; Gross GJ
Circulation; 1995 Sep; 92(5):1236-45. PubMed ID: 7648671
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the protective effect of N-acetylcysteine by different treatments on rat myocardial ischemia-reperfusion injury.
Abe M; Takiguchi Y; Ichimaru S; Tsuchiya K; Wada K
J Pharmacol Sci; 2008 Apr; 106(4):571-7. PubMed ID: 18385540
[TBL] [Abstract][Full Text] [Related]
6. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs.
Vander Heide RS; Reimer KA
Cardiovasc Res; 1996 May; 31(5):711-8. PubMed ID: 8763400
[TBL] [Abstract][Full Text] [Related]
7. Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia.
Woo YJ; Taylor MD; Cohen JE; Jayasankar V; Bish LT; Burdick J; Pirolli TJ; Berry MF; Hsu V; Grand T
J Thorac Cardiovasc Surg; 2004 May; 127(5):1262-9. PubMed ID: 15115981
[TBL] [Abstract][Full Text] [Related]
8. Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs.
Padilla F; Garcia-Dorado D; Agulló L; Barrabés JA; Inserte J; Escalona N; Meyer M; Mirabet M; Pina P; Soler-Soler J
Cardiovasc Res; 2001 Aug; 51(3):592-600. PubMed ID: 11476750
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of N-acetylcysteine on ischaemia-induced myocardial damage in canine heart.
Alberola A; Such L; Gil F; Zaragoza R; Morcillo EJ
Naunyn Schmiedebergs Arch Pharmacol; 1991 May; 343(5):505-10. PubMed ID: 1881461
[TBL] [Abstract][Full Text] [Related]
10. Infarct salvage with liposomal prostaglandin E1 administered by intravenous bolus immediately before reperfusion in a canine infarction-reperfusion model.
Smalling RW; Feld S; Ramanna N; Amirian J; Felli P; Vaughn WK; Swenson C; Janoff A
Circulation; 1995 Aug; 92(4):935-43. PubMed ID: 7641377
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of salvianolate on microvascular flow in a porcine model of myocardial ischaemia and reperfusion.
Han B; Zhang X; Zhang Q; Zhao G; Wei J; Ma S; Zhu W; Wei M
Arch Cardiovasc Dis; 2011 May; 104(5):313-24. PubMed ID: 21693368
[TBL] [Abstract][Full Text] [Related]
12. A useful canine model of ischemic myocardium with coronary retrograde flow diversion, and its application for the study of allopurinol on myocardial infarct size.
Motoe M; Yoshida S
Jpn Circ J; 1991 May; 55(5):490-9. PubMed ID: 2062000
[TBL] [Abstract][Full Text] [Related]
13. Infusion of oxidized glutathione enhances postischemic segment-shortening in dog hearts.
Krieter H; Bauer SF; Schwarz K; van Ackern K; Brückner UB; Rüegg JC
Cardioscience; 1994 Jun; 5(2):115-26. PubMed ID: 7919048
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion.
Forman MB; Pitarys CJ; Vildibill HD; Lambert TL; Ingram DA; Virmani R; Murray JJ
J Am Coll Cardiol; 1992 Jan; 19(1):205-16. PubMed ID: 1729335
[TBL] [Abstract][Full Text] [Related]
15. Preconditioning does not attenuate myocardial stunning.
Ovize M; Przyklenk K; Hale SL; Kloner RA
Circulation; 1992 Jun; 85(6):2247-54. PubMed ID: 1591839
[TBL] [Abstract][Full Text] [Related]
16. Ischemic and reperfusion injury of cyanotic myocardium in chronic hypoxic rat model: changes in cyanotic myocardial antioxidant system.
Nakanishi K; Inoue M; Sugawara E; Sano S
J Thorac Cardiovasc Surg; 1997 Dec; 114(6):1088-96. PubMed ID: 9434704
[TBL] [Abstract][Full Text] [Related]
17. Glutathione redox pathway and reperfusion injury. Effect of N-acetylcysteine on infarct size and ventricular function.
Forman MB; Puett DW; Cates CU; McCroskey DE; Beckman JK; Greene HL; Virmani R
Circulation; 1988 Jul; 78(1):202-13. PubMed ID: 3383404
[TBL] [Abstract][Full Text] [Related]
18. Isoflurane does not produce a second window of preconditioning against myocardial infarction in vivo.
Kehl F; Pagel PS; Krolikowski JG; Gu W; Toller W; Warltier DC; Kersten JR
Anesth Analg; 2002 Nov; 95(5):1162-8, table of contents. PubMed ID: 12401584
[TBL] [Abstract][Full Text] [Related]
19. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning.
Halkos ME; Kerendi F; Corvera JS; Wang NP; Kin H; Payne CS; Sun HY; Guyton RA; Vinten-Johansen J; Zhao ZQ
Ann Thorac Surg; 2004 Sep; 78(3):961-9; discussion 969. PubMed ID: 15337028
[TBL] [Abstract][Full Text] [Related]
20. Endothelial and myocardial cell protection by a cysteine-containing nitric oxide donor after myocardial ischemia and reperfusion.
Lefer DJ; Nakanishi K; Vinten-Johansen J
J Cardiovasc Pharmacol; 1993; 22 Suppl 7():S34-43. PubMed ID: 7504767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
